Washington: Seven new genetic regions associated with pulmonary fibrosis have been identified in a new genome-wide association study of more than 6,000 people.
In the study, researchers at National Jewish Health, the University of Colorado and several other institutions found a number of genes associated with host defense, cell-cell adhesion and DNA repair, which provide clues to possible mechanisms underlying this currently untreatable disease.
"This research gives us several new targets for investigation of pulmonary fibrosis," David Schwartz, MD, senior author on the paper, Professor of Medicine at National Jewish Health and Chair of Medicine the University of Colorado School of Medicine, said.
"We believe that there are several relatively common genetic risk factors, which combine with repeated lung injury to cause this devastating lung disease," he said.
Pulmonary fibrosis is a potentially deadly scarring of lung tissue.
Although there are a number of known contributors to its development, most cases have no known cause.
Without an approved medical therapy, patients with the most common form, idiopathic pulmonary fibrosis, survive an average of only two to three years after diagnosis.
"Pulmonary fibrosis has resisted our attempts to find a clearly beneficial treatment," co-author Kevin K. Brown, MD, Vice Chair of Medicine at National Jewish Health said.
"This study gives us new insights into how the disease develops. By better understanding this, we can better focus future therapies," he said.
The findings have been published online in Nature Genetics.